Organization Overview
Alternative names
dexmedetomidine (precedex) (2022)
Bipolar Disorder (Phase 3)
Carcinoma, Small Cell (Phase 2)
Delirium (Phase 2)
Dementia (Phase 2)
Disease (Phase 3)
Mood Disorders (Phase 3)
Neuroendocrine Tumors (Phase 2)
Pancreatic Neoplasms (Phase 1)
Prostatic Neoplasms (Phase 2)
Psychomotor Agitation (Phase 3)
Psychotic Disorders (Phase 3)
Schizophrenia (Phase 3)
Small Cell Lung Carcinoma (Phase 2)
Substance Withdrawal Syndrome (Phase 2)